CDC NIP/NIC Home Page
|
|
|
CDC NIP/NIC Home Page
|
International Ballroom E
| |||
A3: Prevention of Rotavirus Gastroenteritis in the United States | |||
| In this workshop, presenters will discuss a candidate rotavirus vaccine (RotateqTM) likely to be licensed in the United States in 2006. Safety, efficacy, and the cost-effectiveness of a rotavirus vaccine will be covered. | |||
| Moderators: | Umesh Parashar James Alexander | ||
| 11:00 AM | Introductory Remarks | ||
| 11:05 AM | Recommendations for Pentavalent Bovine-Human Rotavirus Vaccine (PRV) | ||
| 11:25 AM | Safety and Efficacy of a Pentavalent Human-Bovine Reassortant Rotavirus Vaccine -- Penny Heaton | ||
| 11:45 AM | Cost-Effectiveness of a Rotavirus Vaccine in the United States -- Marc-Alain Widdowson | ||
| 12:05 PM | Discussion | ||